Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 5, 2011, Pages 991-998

  Stemmy, Erik J ^a   Balsley, Molly A ^a   Jurjus, Rosalyn A ^a   Damsker, Jesse M ^a   Bukrinsky, Michael I ^a   Constant, Stephanie L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic asthma; Cyclophilins; Cyclosporine A; NIM811

Indexed keywords

CHEMOKINE; CYCLOPHILIN; CYCLOPHILIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; LEUKOCYTE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CYCLOPHILINS; CYCLOSPORINE; FEMALE; LEUKOCYTES; MICE; MICE, INBRED BALB C; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 80555143032     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0007OC     Document Type: Article

References (48)

1. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999;402(Suppl):B5-B11.
2. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789-815. (Pubitemid 38680442)
3. Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1988;1:1129-1132.
4. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-942.
5. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450-463, quiz 464.
6. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255-281. (Pubitemid 29241125)
7. Huang SK, Xiao HQ, Kleine-Tebbe J, Paciotti G,Marsh DG, Lichtenstein LM, Liu MC. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-2694.
8. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
9. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885. (Pubitemid 34496945)
10. Homer RJ, Elias JA. Consequences of long-term inflammation: airway remodeling. Clin Chest Med 2000;21:331-343. (ix.). (Pubitemid 30434643)
11. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001;164:2107-2113. (Pubitemid 34020253)
12. Medoff BD, Thomas SY, Luster AD. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol 2008;26:205-232. (Pubitemid 351600375)
13. + memory T cells are long lived. Immunol Rev 2006;211:49-57.
14. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-174.
15. Harris NL, Watt V, Ronchese F, Le Gros G. Differential T cell function and fate in lymph node and nonlymphoid tissues. J Exp Med 2002;195: 317-326. (Pubitemid 34461489)
16. Brown JR, Kleimberg J, Marini M, Sun G, Bellini A, Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 1998;114:137-146. (Pubitemid 28505710)
17. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997;156:1377-1383. (Pubitemid 27505497)
18. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, Wells TN, Li D, Jeffery PK, Griffiths-Johnson DA, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997;186:601-612. (Pubitemid 27360804)
19. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, Siegelman MH, Cybulsky M, Gutierrez-Ramos JC. Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996;98:2332-2345. (Pubitemid 26394208)
20. Wang P, Heitman J. The cyclophilins. Genome Biol 2005;6:226.
21. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984;226:544-547. (Pubitemid 14018525)
22. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000;87:789-796.
23. Sherry B, Yarlett N, Strupp A, Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc Natl Acad Sci USA 1992;89:3511-3515.
24. Billich A, Winkler G, Aschauer H, Rot A, Peichl P. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med 1997;185:975-980. (Pubitemid 27119882)
25. Suzuki J, Jin ZG, Meoli DF, Matoba T, Berk BC. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res 2006;98:811-817.
26. Tegeder I, Schumacher A, John S, Geiger H, Geisslinger G, Bang H, Brune K. Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol 1997;17:380-386. (Pubitemid 27431977)
27. Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, Bukrinsky MI, Constant SL. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005;175:517-522. (Pubitemid 40884357)
28. Damsker JM, Bukrinsky MI, Constant SL. Preferential chemotaxis of activated human CD41 T cells by extracellular cyclophilin A. J Leukoc Biol 2007;82:613-618. (Pubitemid 47367153)
29. Gwinn WM, Damsker JM, Falahati R, Okwumabua I, Kelly-Welch A, Keegan AD, Vanpouille C, Lee JJ, Dent LA, Leitenberg D, et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J Immunol 2006;177:4870-4879. (Pubitemid 44469823)
30. Xu Q, Leiva MC, Fischkoff SA, Handschumacher RE, Lyttle CR. Leukocyte chemotactic activity of cyclophilin. J Biol Chem 1992; 267:11968-11971.
31. Balsley MA, Malesevic M, Stemmy EJ, Gigley J, Jurjus RA, Herzog D, Bukrinsky MI, Fischer G, Constant SL. A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation. J Immunol 2010;185:7663-7670.
32. Fulkerson PC, Rothenberg ME, Hogan SP. Building a better mouse model: experimental models of chronic asthma. Clin Exp Allergy 2005;35:1251-1253.
33. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004;34:497-507. (Pubitemid 38373015)
34. Billich A, Hammerschmid F, Peichl P,Wenger R, Zenke G, Quesniaux V, Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) Type 1: interference with HIV protein-cyclophilin A interactions. J Virol 1995;69:2451-2461.
35. Rosenwirth B, Billich A, Steinkasserer A, Peichl P, Donatsch P, Lawen A, Wenger R, Traber P. SDZ NIM 811: anti-HIV nonimmunosuppressive natural cyclosporine. Drugs Future 1995;20:579-583.
36. Elekes K, Helyes Z, Kereskai L, Sandor K, Pinter E, Pozsgai G, Tekus V, Banvolgyi A, Nemeth J, Szuts T, et al. Inhibitory effects of synthetic somatostatin receptor Subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse. Eur J Pharmacol 2008;578:313-322.
37. Damsker JM, Okwumabua I, Pushkarsky T, Arora K, Bukrinsky MI, Constant SL. Targeting the chemotactic function of CD147 reduces collagen-induced arthritis. Immunology 2009;126:55-62.
38. Lynch EL, Little FF, Wilson KC, Center DM, Cruikshank WW. Immunomodulatory cytokines in asthmatic inflammation. Cytokine Growth Factor Rev 2003;14:489-502. (Pubitemid 37296022)
39. Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, Dimina D, Ochkur SI, O'Neill K, Colbert D, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 2006;79:1131-1139. (Pubitemid 44835546)
40. Bukrinsky MI. Cyclophilins: unexpected messengers in intercellular communications. Trends Immunol 2002;23:323-325. (Pubitemid 34717897)
41. Quesniaux VF, Schreier MH, Wenger RM, Hiestand PC, Harding MW, Van Regenmortel MH. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity. Eur J Immunol 1987;17:1359-1365. (Pubitemid 17148178)
42. Gallay PA. Cyclophilin inhibitors. Clin Liver Dis 2009;13:403-417.
43. Daum S, Schumann M, Mathea S, Aumuller T, Balsley MA, Constant SL, de Lacroix BF, Kruska F, Braun M, Schiene-Fischer C. Isoform-specific inhibition of cyclophilins. Biochemistry 2009;48: 6268-6277.
44. Mikol V, Kallen J, Walkinshaw MD. X-ray structure of a cyclophilin B/ cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain. Proc Natl Acad Sci USA 1994;91:5183-5186. (Pubitemid 24177817)
45. Malesevic M, Kuhling J, Erdmann F, Balsley MA, Bukrinsky MI, Constant SL, Fischer G. A cyclosporin derivative discriminates between extracellular and intracellular cyclophilins. Angew Chem Int Ed Engl 2010;49:213-215.
46. Bisset LR, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med 2005;11:35-42. (Pubitemid 40189249)
47. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001;1:108-116. (Pubitemid 33741964)
48. Li W, Luo S, Hayes M, He H, Tse FL. Determination of N-methyl-4- isoleucine-cyclosporin (NIM811) in human whole blood by high performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2007;21:249-256. (Pubitemid 46477465)